We are live on ! Find out more
AIH

Aesthetic Medical International Holdings

Delisted

AIH was delisted on the 20th of May, 2024.

1 hedge funds and large institutions have $8.97K invested in Aesthetic Medical International Holdings in 2024 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.93% less ownership

Funds ownership: 0.93%0% (-0.93%)

80% less funds holding

Funds holding: 51 (-4)

93% less capital invested

Capital invested by funds: $133K → $8.97K (-$124K)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 4

Holders
1
Holders Change
-4
Holders Change %
-80%
% of All Funds
0.01%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
Increased
Reduced
Closed
4
Calls
Puts
Net Calls
Net Calls Change

AIH Hedge Fund Activity: Q2 2024 in Review

1 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in Aesthetic Medical International Holdings (AIH) for Q2 2024, worth a combined $8.97K — down 93% from $133K a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of AIH and 0 opened new positions — a net loss of 4 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was IDG Technology Venture Investment IV, exiting entirely with an estimated $119K sold.

  • 1 institutional investor held Aesthetic Medical International Holdings (AIH) as of Q2 2024, down from 5 in Q1 2024.
  • Funds reported $8.97K of Aesthetic Medical International Holdings stock for Q2 2024, down 93% quarter-over-quarter.
  • 0 funds opened new Aesthetic Medical International Holdings positions in Q2 2024 and 4 closed out, a net change of -4 holders.
  • The largest Aesthetic Medical International Holdings seller in Q2 2024 was IDG Technology Venture Investment IV, an estimated $119K sold.

Based on aggregated 13F filings for Q2 2024.